Video: Q&A with Dr. Doug Williamson on the Future of Parkinson's Disease Research

In this video, Doug Williamson, MD, Lundbeck's chief medical officer and senior vice president, North America R&D, answers questions about progress in Parkinson's research. He provides an update on recent innovation in Parkinson's clinical research and he shares bright spots for potential new therapies. “The major steps forward have been in understanding a little bit more about how the disease progresses. That gives us an opportunity to one day to develop treatments that might slow down the progress of the disease or even stop it altogether," he explains.

Watch the video below. 


Parkinson’s Research Update: Multifaceted Approach for a Multifaceted Disease
How insights into Parkinson’s neuropathology are shaping potential transformational approaches.